Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels

INTRODUCTION: Levosimendan is approved for acute heart failure. Within this context, pulmonary hypertension represents a frequent co-morbidity. Hence, the effects of levosimendan on segmental pulmonary vascular resistance (PVR) are relevant. So far, this issue has been not studied. Beyond that the r...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Rieg, Annette Dorothea, Suleiman, Said, Bünting, Nina Andrea, Verjans, Eva, Spillner, Jan, Schnöring, Heike, Kalverkamp, Sebastian, Schröder, Thomas, von Stillfried, Saskia, Braunschweig, Till, Schälte, Gereon, Uhlig, Stefan, Martin, Christian
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7233573/
https://ncbi.nlm.nih.gov/pubmed/32421724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233176
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires